One of the primary reasons Dante’s Soma exists is to address how
technology impacts our lives. That impact is different for just about
every demographic, culture or geography — it’s not one size fits all. We
use Smartphone apps today for a host of entertainment – hurling birds
through the air to hit pigs, capturing music we hear floating out of a
radio
, photographic enhancement, you name it. There is an app for just
about everything these days.
At a recent mobile development summit I hosted, I asked a few people
how many apps they had on their Smartphones – the answers varied – from
20 to 100. I refined my question, how many apps do you use regularly?
The answer became more homogoneous – three to five a day with the
majority being social, entertainment or productivity related, and these
were mobile developers.
So, pushing beyond the social and entertainment apps we consume on a
daily basis causing us to slide farther towards Aldous Huxley’s
prediction that we would amuse our selves to death, along comes the Lifelens Project.
Lifelens has created innovative point-of-care smartphone application
that addresses child mortality rates caused by the lack of detection and
availability of treatment for malaria.
The current state-of-the-art rapid diagnostic tests (RDTs) deployed
throughout sub-Saharan Africa and other parts of the world only have
around a 40% rate of accuracy. The Lifelens’ Smartphone app has been
more than 94% accurate in the tests they have run.
The Lifelens Smartphone app is simple. Take a drop of blood from a
patient and put it on a slide with a marker, a dye that only the
malarial parasite can absorb. Then, take an image of that slide with the
Smartphone equipped with a tiny lens giving 350 times magnification and
you can see the blood cells at the cellular level. With the image
captured in the Smartphone you can take a cell count using a detection
algorithm that identifies different artifacts in the image that
identifies red blood cells and from there, you can identify the malaria
within those red blood cells. Once the Lifelens’ app identifies the
cells, data can be pushed to the web including the GPS coordinates of
that case which allow healthcare works or scientists to see trends as
well as where malaria outbreaks are occurring. There is also a web
portal feature that can put all of the information they have on cases
and lay over a mobile map giving a universal snapshot of where malaria
is clustered globally.
According to Jason Wakizaka,
one of the team members and founders who formulates the user engagement
strategy and interface design for the Lifelens project, you can be out
in the field with no network connection, but you can still make an
accurate diagnosis of malaria. When you return to a place where there is
internet, you can then push all that data which is stored on the device
to the internet into the cloud and it will show up on the case map.
Lifelens says child mortality rates remain unacceptably high in an
era of modern medicine. About 29,000 children under the age of five die
every day, mainly from preventable causes.
This equates to nearly 21 deaths per minute. With a mortality of
15–20%, there are over one million deaths per year due to malaria, 85%
of fatalities occurring with children under five years of age.
The Lifelens Project and their team
of five innovative graduate student-founders from cross academic disciplines (a medical scientist, business manager, software engineer,
user interface designer and business strategy & performance guru
from UBS),
want to directly address and reduce malaria child mortality rates around
the world with the Lifelens’ mobile diagnostic solution. More
importantly, the app can be used by anyone who can operate a basic cell
phone, which according to Lifelens, opens up the possibilities of
shipping devices directly to affected areas because no special training
or language skills are necessary for the operation of the device. This
app has a purpose and will hopefully affect the lives of thousands of
children living under the threat of disease that has no cure.
Source - Forbes.com
No comments:
Post a Comment